這樣，我好對照朋友情況看看她是否適合接受這種治療。
Conditions treated
The FDA-approved indications for CAR T-cell therapy, Yescarta made by Kite Pharma Gilead, is aggressive B-cell non-Hodgkin's lymphoma, including the diagnosis of:
- Diffuse large B-cell lymphoma
- Primary mediastinal B-cell lymphoma
- Large B-cell lymphoma transformed from follicular lymphoma
- Aggressive B-cell lymphoma not otherwise specified (NOS)
Patients who have relapsed or refractory disease after two or more types of prior treatments could be evaluated for CAR T-cell therapy with Yescarta.
In addition, Mayo Clinic has multiple active clinical trials testing CAR T-cell therapy in lymphoma and other cancer types.
請問：
“including the diagnosis of:
- Diffuse large B-cell lymphoma
- Primary mediastinal B-cell lymphoma
- Large B-cell lymphoma transformed from follicular lymphoma
- Aggressive B-cell lymphoma not otherwise specified (NOS)”
這段話是什麽意思啊？是這種療法要做的事？這種療法需要的前提？還是這種療法需要確診上述問題？
拜謝！
